Arcadia Biosciences (RKDA) Reaches $0.65 Yearly Low, VYSTAR CORPORATION (VYST) Sellers Increased By 56.78% Their Shorts

June 14, 2017 - By Peter Erickson

The stock of Arcadia Biosciences Inc (NASDAQ:RKDA) hit a new 52-week low and has $0.60 target or 7.00% below today’s $0.65 share price. The 9 months bearish chart indicates high risk for the $26.54M company. The 1-year low was reported on Jun, 14 by Barchart.com. If the $0.60 price target is reached, the company will be worth $1.86 million less. About 17,069 shares traded. Arcadia Biosciences Inc (NASDAQ:RKDA) has declined 43.32% since June 14, 2016 and is downtrending. It has underperformed by 60.02% the S&P500.

VYSTAR CORPORATION (OTCMKTS:VYST) had an increase of 56.78% in short interest. VYST’s SI was 18,500 shares in June as released by FINRA. Its up 56.78% from 11,800 shares previously. With 145,400 avg volume, 0 days are for VYSTAR CORPORATION (OTCMKTS:VYST)’s short sellers to cover VYST’s short positions. It is 0.00% or $0 reaching $0.125 per share. It is down 0.00% since June 14, 2016 and is . It has underperformed by 16.70% the S&P500.

Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. The company has market cap of $26.54 million. The Firm develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It currently has negative earnings. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market.

Vystar Corporation is the creator and owner of the technology to produce Vytex Natural Rubber Latex . The company has market cap of $14.86 million. The Company’s technology reduces antigenic protein and non-rubbers in natural rubber latex to undetectable levels. It currently has negative earnings. The Firm operates in two divisions: Vytex Division and Kiron Division.